Trial Details
WITHDRAWNBasic Information
| Clinical ID | c1708 |
|---|---|
| Identifier | NCT04643483 |
| Trial Title | A Study to Test Efficacy, Safety, and Pharmacokinetics of Certolizumab Pegol in Children and Adolescents With Moderately to Severely Active Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | DRUG: Certolizumab pegol|DRUG: Adalimumab|DRUG: Placebo |
Participant Information
| Sponsor | UCB Biopharma SRL |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2021-06 |
|---|---|
| Primary Completion Date | 2023-09 |
| Completion Date | 2026-04 |